Zhe Li

Title: Zhe Li - Innovator in Prostate Cancer Research

Introduction

Zhe Li is a notable inventor based in Fort Lee, NJ (US). He has made significant contributions to the field of cancer research, particularly in developing models that closely resemble human diseases. His work is crucial for advancing our understanding of prostate cancer.

Latest Patents

Zhe Li holds a patent for a rodent model of prostate cancer. This innovative disclosure provides a rodent model that comprises a transgene, allowing for prostate-specific expression of an oncogenic protein, such as an SV40 tumor antigen. The model is designed under the control of 5' and 3' regulatory regions of a mouse probasin gene. The rodents developed through this model exhibit progressive forms of prostate tumors that closely resemble the development of human prostate cancer. This patent highlights the potential for improved research methodologies in cancer studies.

Career Highlights

Zhe Li is currently employed at Regeneron Pharmaceuticals, Inc., where he continues to contribute to groundbreaking research in the pharmaceutical industry. His work at Regeneron has positioned him as a key player in the development of innovative therapies.

Collaborations

Zhe Li collaborates with esteemed colleagues, including Chia-Jen Siao and Hoi-Ching Lee. These partnerships enhance the research efforts and foster a collaborative environment that drives innovation in cancer research.

Conclusion

Zhe Li's contributions to prostate cancer research through his innovative patent and collaborative efforts at Regeneron Pharmaceuticals, Inc. underscore his importance in the field. His work not only advances scientific understanding but also paves the way for future therapeutic developments.